| UniProt ID | E41L5_HUMAN | |
|---|---|---|
| UniProt AC | Q9HCM4 | |
| Protein Name | Band 4.1-like protein 5 | |
| Gene Name | EPB41L5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 733 | |
| Subcellular Localization | Cytoplasm. Cell junction, adherens junction. Associated with the plasma membrane. Colocalizes with CTNNB1, an adherens junction marker (By similarity).. | |
| Protein Description | May contribute to the correct positioning of tight junctions during the establishment of polarity in epithelial cells.. | |
| Protein Sequence | MLSFFRRTLGRRSMRKHAEKERLREAQRAATHIPAAGDSKSIITCRVSLLDGTDVSVDLPKKAKGQELFDQIMYHLDLIESDYFGLRFMDSAQVAHWLDGTKSIKKQVKIGSPYCLHLRVKFYSSEPNNLREELTRYLFVLQLKQDILSGKLDCPFDTAVQLAAYNLQAELGDYDLAEHSPELVSEFRFVPIQTEEMELAIFEKWKEYRGQTPAQAETNYLNKAKWLEMYGVDMHVVKARDGNDYSLGLTPTGVLVFEGDTKIGLFFWPKITRLDFKKNKLTLVVVEDDDQGKEQEHTFVFRLDHPKACKHLWKCAVEHHAFFRLRGPVQKSSHRSGFIRLGSRFRYSGKTEYQTTKTNKARRSTSFERRPSKRYSRRTLQMKACATKPEELSVHNNVSTQSNGSQQAWGMRSALPVSPSISSAPVPVEIENLPQSPGTDQHDRKCIPLNIDLLNSPDLLEATIGDVIGASDTMETSQALNDVNVATRLPGLGEPEVEYETLKDTSEKLKQLEMENSPLLSPRSNIDVNINSQEEVVKLTEKCLNNVIESPGLNVMRVPPDFKSNILKAQVEAVHKVTKEDSLLSHKNANVQDAATNSAVLNENNVPLPKESLETLMLITPADSGSVLKEATDELDALLASLTENLIDHTVAPQVSSTSMITPRWIVPQSGAMSNGLAGCEMLLTGKEGHGNKDGISLISPPAPFLVDAVTSSGPILAEEAVLKQKCLLTTEL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MLSFFRRTLG -----CHHHHHHHHC | 22.50 | 24719451 | |
| 31 | Phosphorylation | REAQRAATHIPAAGD HHHHHHHHCCCCCCC | 21.25 | 28102081 | |
| 39 | Phosphorylation | HIPAAGDSKSIITCR CCCCCCCCCEEEEEE | 27.64 | 28464451 | |
| 40 (in isoform 3) | Ubiquitination | - | 50.87 | 21890473 | |
| 40 (in isoform 2) | Ubiquitination | - | 50.87 | 21890473 | |
| 40 (in isoform 1) | Ubiquitination | - | 50.87 | 21890473 | |
| 40 | Ubiquitination | IPAAGDSKSIITCRV CCCCCCCCEEEEEEE | 50.87 | 22817900 | |
| 40 (in isoform 4) | Ubiquitination | - | 50.87 | 21890473 | |
| 41 | Phosphorylation | PAAGDSKSIITCRVS CCCCCCCEEEEEEEE | 24.15 | 24117733 | |
| 44 | Phosphorylation | GDSKSIITCRVSLLD CCCCEEEEEEEEECC | 7.81 | 25072903 | |
| 151 | Ubiquitination | KQDILSGKLDCPFDT HHHHHCCCCCCCHHH | 37.46 | 29901268 | |
| 223 | Ubiquitination | AETNYLNKAKWLEMY HHHHHHHHHHHHHHH | 49.07 | 29901268 | |
| 230 | Phosphorylation | KAKWLEMYGVDMHVV HHHHHHHHCCEEEEE | 12.48 | 20736484 | |
| 276 | Phosphorylation | PKITRLDFKKNKLTL CCCEEEECCCCEEEE | 16.76 | 32645325 | |
| 278 | Ubiquitination | ITRLDFKKNKLTLVV CEEEECCCCEEEEEE | 60.35 | 23000965 | |
| 347 | Phosphorylation | RLGSRFRYSGKTEYQ EECCEEEECCCEEEE | 21.04 | 28796482 | |
| 348 | Phosphorylation | LGSRFRYSGKTEYQT ECCEEEECCCEEEEE | 29.56 | 23927012 | |
| 350 | Ubiquitination | SRFRYSGKTEYQTTK CEEEECCCEEEEECC | 32.04 | 23000965 | |
| 351 | Phosphorylation | RFRYSGKTEYQTTKT EEEECCCEEEEECCC | 43.37 | 28796482 | |
| 353 | Phosphorylation | RYSGKTEYQTTKTNK EECCCEEEEECCCCH | 19.18 | 28796482 | |
| 355 | Phosphorylation | SGKTEYQTTKTNKAR CCCEEEEECCCCHHH | 29.38 | 28796482 | |
| 356 | Phosphorylation | GKTEYQTTKTNKARR CCEEEEECCCCHHHC | 21.98 | 28796482 | |
| 364 | Phosphorylation | KTNKARRSTSFERRP CCCHHHCCCCCCCCC | 23.89 | 26699800 | |
| 365 | Phosphorylation | TNKARRSTSFERRPS CCHHHCCCCCCCCCC | 35.31 | 25954137 | |
| 366 | Phosphorylation | NKARRSTSFERRPSK CHHHCCCCCCCCCCC | 26.76 | 30576142 | |
| 372 | Phosphorylation | TSFERRPSKRYSRRT CCCCCCCCCCCCCCC | 28.14 | 23882029 | |
| 376 | Phosphorylation | RRPSKRYSRRTLQMK CCCCCCCCCCCEEEH | 21.22 | 24719451 | |
| 387 | Phosphorylation | LQMKACATKPEELSV EEEHHHCCCHHHEEC | 47.19 | 28348404 | |
| 393 | Phosphorylation | ATKPEELSVHNNVST CCCHHHEECCCCCCC | 25.30 | 28348404 | |
| 399 | Phosphorylation | LSVHNNVSTQSNGSQ EECCCCCCCCCCCCC | 23.89 | 28348404 | |
| 400 | Phosphorylation | SVHNNVSTQSNGSQQ ECCCCCCCCCCCCCC | 31.56 | 28348404 | |
| 402 | Phosphorylation | HNNVSTQSNGSQQAW CCCCCCCCCCCCCCC | 43.16 | 28348404 | |
| 405 | Phosphorylation | VSTQSNGSQQAWGMR CCCCCCCCCCCCCCC | 24.30 | 28348404 | |
| 413 | Phosphorylation | QQAWGMRSALPVSPS CCCCCCCCCCCCCCC | 25.84 | 28102081 | |
| 418 (in isoform 2) | Phosphorylation | - | 15.81 | 19276368 | |
| 418 | Phosphorylation | MRSALPVSPSISSAP CCCCCCCCCCCCCCC | 15.81 | 25159151 | |
| 420 | Phosphorylation | SALPVSPSISSAPVP CCCCCCCCCCCCCCC | 27.83 | 25159151 | |
| 422 | Phosphorylation | LPVSPSISSAPVPVE CCCCCCCCCCCCCEE | 25.45 | 30266825 | |
| 423 | Phosphorylation | PVSPSISSAPVPVEI CCCCCCCCCCCCEEE | 34.62 | 30266825 | |
| 431 | Ubiquitination | APVPVEIENLPQSPG CCCCEEEECCCCCCC | 38.93 | 23000965 | |
| 436 | Ubiquitination | EIENLPQSPGTDQHD EEECCCCCCCCCHHC | 24.29 | 23000965 | |
| 436 (in isoform 2) | Phosphorylation | - | 24.29 | 22210691 | |
| 436 | Phosphorylation | EIENLPQSPGTDQHD EEECCCCCCCCCHHC | 24.29 | 30266825 | |
| 438 | Ubiquitination | ENLPQSPGTDQHDRK ECCCCCCCCCHHCCC | 47.36 | 21890473 | |
| 439 | Phosphorylation | NLPQSPGTDQHDRKC CCCCCCCCCHHCCCE | 35.55 | 30266825 | |
| 439 (in isoform 2) | Phosphorylation | - | 35.55 | 22210691 | |
| 466 | Ubiquitination | LLEATIGDVIGASDT HHHHHHHHHHCCCCH | 25.63 | 23000965 | |
| 470 | Ubiquitination | TIGDVIGASDTMETS HHHHHHCCCCHHHHH | 7.97 | 23000965 | |
| 476 (in isoform 2) | Phosphorylation | - | 18.47 | 28442448 | |
| 477 (in isoform 2) | Phosphorylation | - | 10.51 | 28442448 | |
| 491 | Ubiquitination | NVATRLPGLGEPEVE CHHHCCCCCCCCCCC | 51.40 | 21890473 | |
| 496 | Ubiquitination | LPGLGEPEVEYETLK CCCCCCCCCCCEECC | 43.61 | 22817900 | |
| 499 | Phosphorylation | LGEPEVEYETLKDTS CCCCCCCCEECCCHH | 21.27 | 25884760 | |
| 501 | Phosphorylation | EPEVEYETLKDTSEK CCCCCCEECCCHHHH | 37.90 | 26471730 | |
| 503 | Ubiquitination | EVEYETLKDTSEKLK CCCCEECCCHHHHHH | 67.39 | 23000965 | |
| 503 (in isoform 3) | Ubiquitination | - | 67.39 | - | |
| 504 | Ubiquitination | VEYETLKDTSEKLKQ CCCEECCCHHHHHHH | 59.59 | 23000965 | |
| 507 | Ubiquitination | ETLKDTSEKLKQLEM EECCCHHHHHHHHHH | 65.58 | 23000965 | |
| 508 (in isoform 4) | Ubiquitination | - | 61.83 | 21890473 | |
| 508 (in isoform 3) | Ubiquitination | - | 61.83 | 21890473 | |
| 508 | Ubiquitination | TLKDTSEKLKQLEME ECCCHHHHHHHHHHH | 61.83 | 23000965 | |
| 508 (in isoform 1) | Ubiquitination | - | 61.83 | 21890473 | |
| 510 (in isoform 1) | Ubiquitination | - | 65.00 | 21890473 | |
| 510 (in isoform 4) | Ubiquitination | - | 65.00 | 21890473 | |
| 510 | Ubiquitination | KDTSEKLKQLEMENS CCHHHHHHHHHHHCC | 65.00 | 23000965 | |
| 510 (in isoform 3) | Ubiquitination | - | 65.00 | 21890473 | |
| 515 | Ubiquitination | KLKQLEMENSPLLSP HHHHHHHHCCCCCCC | 45.22 | 23000965 | |
| 517 | Phosphorylation | KQLEMENSPLLSPRS HHHHHHCCCCCCCCC | 12.01 | 30266825 | |
| 521 | Phosphorylation | MENSPLLSPRSNIDV HHCCCCCCCCCCCCC | 26.42 | 26055452 | |
| 524 | Phosphorylation | SPLLSPRSNIDVNIN CCCCCCCCCCCCCCC | 41.33 | 30266825 | |
| 532 | Phosphorylation | NIDVNINSQEEVVKL CCCCCCCCHHHHHHH | 34.86 | 30266825 | |
| 538 | Ubiquitination | NSQEEVVKLTEKCLN CCHHHHHHHHHHHHH | 55.67 | 23000965 | |
| 542 | Ubiquitination | EVVKLTEKCLNNVIE HHHHHHHHHHHHHHH | 38.49 | 23000965 | |
| 550 | Phosphorylation | CLNNVIESPGLNVMR HHHHHHHCCCCCEEE | 17.10 | 30266825 | |
| 563 (in isoform 4) | Ubiquitination | - | 50.39 | 21890473 | |
| 563 (in isoform 1) | Ubiquitination | - | 50.39 | 21890473 | |
| 563 (in isoform 3) | Ubiquitination | - | 50.39 | 21890473 | |
| 563 | Ubiquitination | MRVPPDFKSNILKAQ EECCCCHHHHHHHHH | 50.39 | 22817900 | |
| 568 | Ubiquitination | DFKSNILKAQVEAVH CHHHHHHHHHHHHHH | 32.73 | 22817900 | |
| 576 | Ubiquitination | AQVEAVHKVTKEDSL HHHHHHHHCCCHHHH | 45.03 | 23000965 | |
| 579 (in isoform 3) | Ubiquitination | - | 63.61 | - | |
| 579 | Ubiquitination | EAVHKVTKEDSLLSH HHHHHCCCHHHHHCC | 63.61 | 23000965 | |
| 582 | Phosphorylation | HKVTKEDSLLSHKNA HHCCCHHHHHCCCCC | 32.09 | 28857561 | |
| 585 | Phosphorylation | TKEDSLLSHKNANVQ CCHHHHHCCCCCCHH | 37.39 | 25002506 | |
| 587 | Ubiquitination | EDSLLSHKNANVQDA HHHHHCCCCCCHHHH | 55.14 | 23000965 | |
| 587 (in isoform 3) | Ubiquitination | - | 55.14 | - | |
| 610 | Ubiquitination | ENNVPLPKESLETLM CCCCCCCHHHHCCEE | 68.56 | 30230243 | |
| 620 | Phosphorylation | LETLMLITPADSGSV HCCEEEECCCCCCHH | 14.41 | 28270605 | |
| 624 | Phosphorylation | MLITPADSGSVLKEA EEECCCCCCHHHHHH | 34.76 | 28270605 | |
| 626 | Phosphorylation | ITPADSGSVLKEATD ECCCCCCHHHHHHHH | 28.38 | 28270605 | |
| 632 | Phosphorylation | GSVLKEATDELDALL CHHHHHHHHHHHHHH | 30.97 | - | |
| 677 (in isoform 4) | Phosphorylation | - | 4.30 | 22617229 | |
| 700 | Phosphorylation | KDGISLISPPAPFLV CCCEEEECCCCCCCC | 30.08 | 29496963 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of E41L5_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of E41L5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of E41L5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| CHD9_HUMAN | CHD9 | physical | 28514442 | |
| URFB1_HUMAN | UHRF1BP1 | physical | 28514442 | |
| SET1A_HUMAN | SETD1A | physical | 28514442 | |
| CXXC1_HUMAN | CXXC1 | physical | 28514442 | |
| CWC22_HUMAN | CWC22 | physical | 28514442 | |
| NAF1_HUMAN | NAF1 | physical | 28514442 | |
| BD1L1_HUMAN | BOD1L1 | physical | 28514442 | |
| HECD1_HUMAN | HECTD1 | physical | 28514442 | |
| H2B1O_HUMAN | HIST1H2BO | physical | 28514442 | |
| AF9_HUMAN | MLLT3 | physical | 28514442 | |
| BRD2_HUMAN | BRD2 | physical | 28514442 | |
| DCAF5_HUMAN | DCAF5 | physical | 28514442 | |
| FHL2_HUMAN | FHL2 | physical | 28514442 | |
| DCAF8_HUMAN | DCAF8 | physical | 28514442 | |
| NAGK_HUMAN | NAGK | physical | 28514442 | |
| FNTA_HUMAN | FNTA | physical | 28514442 | |
| CWC27_HUMAN | CWC27 | physical | 28514442 | |
| VANG1_HUMAN | VANGL1 | physical | 28514442 | |
| AFF4_HUMAN | AFF4 | physical | 28514442 | |
| UBE2O_HUMAN | UBE2O | physical | 28514442 | |
| AP3B1_HUMAN | AP3B1 | physical | 28514442 | |
| ASH2L_HUMAN | ASH2L | physical | 28514442 | |
| MIB1_HUMAN | MIB1 | physical | 27510968 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436, AND MASSSPECTROMETRY. | |